Structure and function of factor XI.

Blood
J EmsleyDavid Gailani

Abstract

Factor XI (FXI) is the zymogen of an enzyme (FXIa) that contributes to hemostasis by activating factor IX. Although bleeding associated with FXI deficiency is relatively mild, there has been resurgence of interest in FXI because of studies indicating it makes contributions to thrombosis and other processes associated with dysregulated coagulation. FXI is an unusual dimeric protease, with structural features that distinguish it from vitamin K-dependent coagulation proteases. The recent availability of crystal structures for zymogen FXI and the FXIa catalytic domain have enhanced our understanding of structure-function relationships for this molecule. FXI contains 4 "apple domains" that form a disk structure with extensive interfaces at the base of the catalytic domain. The characterization of the apple disk structure, and its relationship to the catalytic domain, have provided new insight into the mechanism of FXI activation, the interaction of FXIa with the substrate factor IX, and the binding of FXI to platelets. Analyses of missense mutations associated with FXI deficiency have provided additional clues to localization of ligand-binding sites on the protein surface. Together, these data will facilitate efforts to understand t...Continue Reading

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·B Osterud, S I Rapaport
Dec 1, 1977·The Journal of Clinical Investigation·R E ThompsonA P Kaplan
Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·R J MandleA P Kaplan
May 19, 1992·Biochemistry·J C MeijersD W Chung
Sep 2, 1991·Science·D Gailani, G J Broze
Jul 18, 1991·The New England Journal of Medicine·R AsakaiU Seligsohn
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R AsakaiE W Davie
Jul 1, 1986·Biochemistry·J S GreengardJ H Griffin
Aug 1, 1988·British Journal of Haematology·P H Bolton-MaggsP B Kernoff
Feb 1, 1980·The Journal of Clinical Investigation·C F Scott, R W Colman
Feb 16, 1996·The Journal of Biological Chemistry·F A Baglia, P N Walsh
Nov 15, 1996·The Journal of Biological Chemistry·Y Sun, D Gailani
Mar 10, 1998·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·B BrennerU Seligsohn
Jun 20, 1998·The Journal of Biological Chemistry·D H HoP N Walsh
Nov 13, 1998·The Journal of Biological Chemistry·M ZhaoD Gailani
Dec 14, 1999·The Journal of Biological Chemistry·M F SunD Gailani
Mar 9, 2000·The New England Journal of Medicine·J C MeijersF R Rosendaal
Nov 28, 2000·The Journal of Biological Chemistry·R Dorfman, P N Walsh
Jun 20, 2001·Biochemistry·K O Badellino, P N Walsh
Jul 27, 2001·Acta Crystallographica. Section D, Biological Crystallography·E G HuizingaP Gros
Dec 26, 2001·The Journal of Biological Chemistry·Thomas RennéWerner Müller-Esterl
Dec 20, 2002·International Immunopharmacology·Thomas RennéWerner Müller-Esterl
Dec 24, 2002·The Journal of Biological Chemistry·Aysar AktimurJohn R Toomey
Jan 30, 2003·Trends in Cardiovascular Medicine·Amy E Schmidt, S Paul Bajaj
Nov 25, 2003·Journal of Thrombosis and Haemostasis : JTH·Q ChengD Gailani
Mar 11, 2004·Journal of Thrombosis and Haemostasis : JTH·G A AllenD M Monroe
Aug 20, 2004·The Journal of Biological Chemistry·Frank A BagliaPeter N Walsh

❮ Previous
Next ❯

Citations

Jan 16, 2013·Journal of Medicinal Chemistry·Rami A Al-HoraniUmesh R Desai
Mar 15, 2013·The New England Journal of Medicine·Bill Giannakopoulos, Steven A Krilis
May 26, 2012·Obstetrical & Gynecological Survey·Ryan G StewardThomas M Price
Mar 16, 2013·Thrombosis and Haemostasis·M PathakJ Emsley
Apr 30, 2011·Blood·Anton MatafonovDavid Gailani
Dec 24, 2011·Blood·David Gailani
Aug 3, 2011·Journal of Leukocyte Biology·Asako ItakuraOwen J T McCarty
Jan 11, 2014·Journal of Medicinal Chemistry·Mimi L QuanRuth R Wexler
Nov 30, 2013·Thrombosis·Andreas Eisenreich
Apr 25, 2014·Thrombosis Research·David GailaniJonas Emsley
Sep 13, 2013·Current Atherosclerosis Reports·Henri M H SpronkHugo ten Cate
Nov 29, 2012·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Juwon KimKyung-A Lee
Oct 4, 2012·Topics in Companion Animal Medicine·Maureen McMichael
Dec 14, 2011·Biochemical and Biophysical Research Communications·Brian L HenryUmesh R Desai
Apr 14, 2016·Blood Cells, Molecules & Diseases·Yanyan ShaoHongli Wang
Mar 31, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·F BauduerUNKNOWN French Postmarketing Study Group
Oct 15, 2013·Journal of Thrombosis and Haemostasis : JTH·Y GengD Gailani
Apr 27, 2013·Journal of Thrombosis and Haemostasis : JTH·Y GengD Gailani
Nov 22, 2011·British Journal of Haematology·Paul GuéguenBrigitte Pan-Petesch
Oct 12, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·G CastamanS Duga
May 16, 2015·Journal of Thrombosis and Haemostasis : JTH·D GailaniA Gruber
Jul 1, 2015·BMC Evolutionary Biology·Ângela M RibeiroRute R da Fonseca
Dec 28, 2010·Journal of Molecular Biology·Brian PereiraMarlene Belfort
Dec 27, 2011·Thrombosis Research·Rong HeShilin He
Jan 17, 2015·Bioorganic & Medicinal Chemistry Letters·James R CorteMimi L Quan
May 6, 2014·Drug Discovery Today·Zhu ChenBrian Hawes
Jun 3, 2014·Drug Discovery Today·Charles E Bane, David Gailani
Jan 10, 2012·Biophysical Journal·Aaron L FogelsonKarin Leiderman
Mar 22, 2013·Blood·Yipeng GengDavid Gailani
May 25, 2016·Expert Review of Hematology·Allison P Wheeler, David Gailani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.